Persistent tissue hypoperfusion improves risk stratification beyond vasopressor dose in refractory septic shock: a secondary analysis of the ANDROMEDA-SHOCK-2 trial
Eduardo Kattan, Gustavo A. Ospina-Tascón, Nicolas Orozco, J C Teboul et autres
cl, ru, fr, co, ch, at, de, mx, us, it, in, es, pl, br, be, nl (code pays fourni par la source)